Aldosterone Nongenomically Worsens Ischemia Via Protein Kinase C-Dependent Pathways in Hypoperfused Canine Hearts
- 1 July 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 46 (1), 113-117
- https://doi.org/10.1161/01.hyp.0000171184.84077.80
Abstract
Rapid nongenomic actions of aldosterone independent of mineralocorticoid receptors (MRs) on vascular tone are divergent. Until now, the rapid nongenomic actions of aldosterone on vascular tone of coronary artery and cardiac function in the in vivo ischemic hearts were not still fully estimated. Furthermore, although aldosterone can modulate protein kinase C (PKC) activity, there is no clear consensus whether PKC is involved in the nongenomic actions of aldosterone on the ischemic hearts. In open chest dogs, the selective infusion of aldosterone into the left anterior descending coronary artery (LAD) reduced coronary blood flow (CBF) in the nonischemic hearts in a dose-dependent manner. Also, in the ischemic state that CBF was decreased to 33% of the baseline, the intracoronary administration of aldosterone (0.1 nmol/L) rapidly decreased CBF (37.4±3.8 to 19.3±5.2 mL/100 g/min; P P P <0.05). The decrease in CBF was reproduced by the infusion of bovine serum albumin-conjugated aldosterone. Notably, these aldosterone-induced deteriorations of myocardial contractile and metabolic functions were blunted by the co-administration of GF109203X, an inhibitor of PKC, but not spironolactone. In addition, aldosterone activated vascular PKC. These results indicate that aldosterone nongenomically induces vasoconstriction via PKC-dependent pathways possibly through membrane receptors, which leads to the worsening of the cardiac contractile and metabolic functions in the ischemic hearts. Elevation of plasma or cardiac aldosterone levels may be deleterious to ischemic heart disease through its nongenomic effects.Keywords
This publication has 16 references indexed in Scilit:
- Rapid Inhibition of Vasoconstriction in Renal Afferent Arterioles by AldosteroneCirculation Research, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Aldosterone induces contraction of the resistance arteries in manAtherosclerosis, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs.JCI Insight, 1998
- Role of Protein Kinase C-α in Activation of Ecto-5′-nucleotidase in the Preconditioned Canine MyocardiumBiochemical and Biophysical Research Communications, 1997
- Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins.JCI Insight, 1997
- Modulation of Cytosolic Protein Kinase C and Calcium Ion Activity by Steroid Hormones in Rat Distal ColonPublished by Elsevier BV ,1996
- Rapid Aldosterone Signaling in Vascular Smooth-Muscle Cells - Involvement of Phospholipase-C, Diacylglycerol and Protein-Kinase-C-αBiochemical and Biophysical Research Communications, 1995
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980